ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Atazanavir-Mepha 300mg, Kapseln - 30
66339003 Mepha Pharma AG
Atazanavir-Mepha 300mg, Kapseln19.09.2017
Generic19.09.2017
Atazanavir (J05AE08) 
WHO-DDD 
08.03.30
08.03. 
A  
Yes 
IP 
353.72No
    
10 %401.10
7680663390033Synthetika
7737277 
Composition
atazanavirum 300 mg ut atazanaviri sulfas 341.744 mg, lactosum monohydricum 134.406 mg, crospovidonum, magnesii stearas, Kapselhülle: gelatina, E 171, E 132, E 172 (rubrum), E 172 (flavum), Drucktinte: lacca, E 172 (nigrum), propylenglycolum, ammoniae solutio 28 per centum, pro capsula.
Packungsbestandteile
Capsules 
 
Active AgentDose
Atazanavir300 mg
BAG: Active AgentDose
Atazanavir300 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
(Nigrum)  
(Rubrum)  
Ammoniae Solutio28  
Crospovidonum  
E 132 color.
E 171 color.
E 172 color.
Gelatina Kapselhülle
Lacca Drucktinte
Lactose Monohydrate134.406 mg 
Magnesii Stearas  
Per Centum  
Pro Capsula  
Propylenglycol  
 
Source
Data was imported : 05.01.2024 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home